Pharmaceutical preparation comprising an active dispersed on...

Details Pharmaceutical preparation comprising an active dispersed on... Pharmaceutical preparation comprising an active dispersed on...

2011-05-31

2011-05-31

Vu, Jake M. (Department: 1618)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

C424S484000, C424S489000, C424S465000, C424S469000

Reexamination Certificate

active

07951398

ABSTRACT:
The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a large number of pharmaceutical dosage forms. In the new preparation, an active ingredient is present essentially uniformly dispersed in an excipient matrix composed of one or more excipients selected from the group of fatty alcohols, triglycerides, partial triglycerides and fatty acid esters.

REFERENCES:
patent: 3065142 (1962-11-01), Antonides
patent: 4006227 (1977-02-01), Gallegos et al.
patent: 4464372 (1984-08-01), Bristol et al.
patent: 4833149 (1989-05-01), Press
patent: 5041442 (1991-08-01), Romero et al.
patent: 5188838 (1993-02-01), Deleuil et al.
patent: 5380532 (1995-01-01), Deleuil et al.
patent: 5429824 (1995-07-01), June
patent: 5665730 (1997-09-01), Senn-Bilfinger et al.
patent: 5677302 (1997-10-01), Karimian et al.
patent: 5719161 (1998-02-01), Rainer
patent: 5762953 (1998-06-01), Venkateshwaran
patent: 6114537 (2000-09-01), Karimian et al.
patent: 6124313 (2000-09-01), Grundler et al.
patent: 6231885 (2001-05-01), Carrara
patent: 7147869 (2006-12-01), Dietrich et al.
patent: 7175854 (2007-02-01), Dietrich et al.
patent: 7357943 (2008-04-01), Linder et al.
patent: 30 11 490 (1981-03-01), None
patent: 36 22 036 (1987-01-01), None
patent: 39 17 232 (1990-11-01), None
patent: 691 01 493 (1994-08-01), None
patent: 199 25 710 (2000-12-01), None
patent: 0 033 094 (1981-08-01), None
patent: 0 068 378 (1983-01-01), None
patent: 0 120 589 (1984-10-01), None
patent: 0 125 756 (1984-11-01), None
patent: 0 165 545 (1985-12-01), None
patent: 0 204 285 (1986-12-01), None
patent: 0 228 006 (1987-07-01), None
patent: 0 259 174 (1988-03-01), None
patent: 0 261 912 (1988-03-01), None
patent: 0 264 883 (1988-04-01), None
patent: 0 266 890 (1988-05-01), None
patent: 0 268 989 (1988-06-01), None
patent: 0 307 078 (1989-03-01), None
patent: 0 308 917 (1989-03-01), None
patent: 0 330 485 (1989-08-01), None
patent: 0 368 158 (1990-05-01), None
patent: 0 387 821 (1990-09-01), None
patent: 0 393 926 (1990-10-01), None
patent: 0 399 267 (1990-11-01), None
patent: 0 438 359 (1991-07-01), None
patent: 0 509 974 (1992-10-01), None
patent: 0 535 529 (1993-04-01), None
patent: 0 537 532 (1993-04-01), None
patent: 0 563 024 (1993-09-01), None
patent: 2-270873 (1990-11-01), None
patent: 3-31280 (1991-02-01), None
patent: 3-284622 (1991-12-01), None
patent: 3-284686 (1991-12-01), None
patent: 5-271070 (1993-10-01), None
patent: 9-59152 (1997-03-01), None
patent: 11/152224 (1999-06-01), None
patent: 2000-86502 (2000-03-01), None
patent: 2000-516633 (2000-12-01), None
patent: 89/00570 (1989-01-01), None
patent: 91/14677 (1991-10-01), None
patent: 91/17164 (1991-11-01), None
patent: 91/18887 (1991-12-01), None
patent: 92/06979 (1992-04-01), None
patent: 92/12969 (1992-08-01), None
patent: 92/21328 (1992-12-01), None
patent: 93/08190 (1993-04-01), None
patent: 93/12090 (1993-06-01), None
patent: 93/12090 (1993-06-01), None
patent: 93/15055 (1993-08-01), None
patent: 93/15056 (1993-08-01), None
patent: 93/15071 (1993-08-01), None
patent: 94/14795 (1994-07-01), None
patent: 94/24130 (1994-10-01), None
patent: 97/25030 (1997-07-01), None
patent: 98/07400 (1998-02-01), None
patent: 00/10999 (2000-03-01), None
Hafner, et al., “Additive effects of phosphodiesterase-4 inhibition on effecs of rSP-C surfactant”,AM J Respir Crit Care Med. vol. 161, No. 5, pp. 1495-1500, (2000).
Lewis, et al., “The physical and chemical stability of suspensions of sustained-released diclofenac microspheres”,J. Microencapsulation, vol. 15, No. 5, pp. 555-567, (1998).
Safety Data Sheet, Crodesta SL40, HB03791, Aqua and Sucrose Cocoate and Alcohol, Croda Europe Ltd., 5 pages, (2004).
Safety Data Sheet, Crodesta F20, HB03668, Sucrose Distearate, Croda Europe Ltd., 5 pages (2008).
Safety Data Sheet, Crodesta F50, HB03669, Sucrose Distearate, Croda Europe Ltd., 5 pages (2005).
Safety Data Sheet, Crodesta F10, HB03671, Sucrose Distearate, Croda Europe Ltd., 5 pages, (2005).
Safety Data Sheet, Crodesta F110, HB03722, Sucrose Stearate and Sucrose Distearate, Croda Europe Ltd., 5 pages, (2005).
Safety Data Sheet, Crodesta F160, HB03750, Sucrose Stearate, Croda Europe Ltd., 4 pages, (2005).

Affiliated with

Also associated with

Rating

Pharmaceutical preparation comprising an active dispersed on... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical preparation comprising an active dispersed on..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical preparation comprising an active dispersed on... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2681160